Bioactive inorganic nanomaterials for cancer theranostics
Z Pei, H Lei, L Cheng - Chemical Society Reviews, 2023 - pubs.rsc.org
Bioactive materials are a special class of biomaterials that can react in vivo to induce a
biological response or regulate biological functions, thus achieving a better curative effect …
biological response or regulate biological functions, thus achieving a better curative effect …
Boosting checkpoint immunotherapy with biomaterials
The immune checkpoint blockade (ICB) therapy has revolutionized the field of cancer
treatment, while low response rates and systemic toxicity limit its clinical outcomes. With the …
treatment, while low response rates and systemic toxicity limit its clinical outcomes. With the …
Surface modified lanthanide upconversion nanoparticles for drug delivery, cellular uptake mechanism, and current challenges in NIR-driven therapies
AA Ansari, AK Parchur, G Chen - Coordination chemistry reviews, 2022 - Elsevier
Abstract Lanthanides (Ln 3+) are a particular class of optical materials and are regularly
utilized as a structure block for architectures of optoelectronic frameworks because of their …
utilized as a structure block for architectures of optoelectronic frameworks because of their …
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
Q Cheng, Y Kang, B Yao, J Dong, Y Zhu… - Advanced …, 2023 - Wiley Online Library
The advent of immunotherapy has marked a new era in cancer treatment, offering significant
clinical benefits. Cell membrane as drug delivery materials has played a crucial role in …
clinical benefits. Cell membrane as drug delivery materials has played a crucial role in …
[HTML][HTML] Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison
X Zhang, H Cui, W Zhang, Z Li, J Gao - Bioactive Materials, 2023 - Elsevier
Tumor vaccination is a promising approach for tumor immunotherapy because it presents
high specificity and few side effects. However, tumor vaccines that contain only a single …
high specificity and few side effects. However, tumor vaccines that contain only a single …
A general biomineralization strategy to synthesize autologous cancer vaccines with cGAS-STING activating capacity for postsurgical immunotherapy
Autologous cancer vaccines constructed by nonproliferative whole tumor cells or tumor
lysates together with appropriate adjuvants represent a promising strategy to suppress …
lysates together with appropriate adjuvants represent a promising strategy to suppress …
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
The advent of immunotherapy has revolutionized the treating modalities of cancer. Cancer
vaccine, aiming to harness the host immune system to induce a tumor‐specific killing effect …
vaccine, aiming to harness the host immune system to induce a tumor‐specific killing effect …
Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane
Y Li, H Zhang, R Wang, Y Wang, R Li, M Zhu… - Advanced …, 2023 - Wiley Online Library
Despite the promise in whole‐tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic‐antibody‐boosted tumor cell nanovaccines are …
costimulatory signals. Here, agonistic‐antibody‐boosted tumor cell nanovaccines are …
Lymph node-targeting nanovaccines for cancer immunotherapy
Q Wang, Z Wang, X Sun, Q Jiang, B Sun, Z He… - Journal of Controlled …, 2022 - Elsevier
Cancer immunotherapies such as tumor vaccines, chimeric antigen receptor T cells and
immune checkpoint blockades, have attracted tremendous attention. Among them, tumor …
immune checkpoint blockades, have attracted tremendous attention. Among them, tumor …
[HTML][HTML] Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
P Sharma, M Otto - Bioactive Materials, 2024 - Elsevier
Cancer immunotherapy has gained momentum for treating malignant tumors over the past
decade. Checkpoint blockade and chimeric antigen receptor cell therapy (CAR-T) have …
decade. Checkpoint blockade and chimeric antigen receptor cell therapy (CAR-T) have …